Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+12.90%
-18.60%
-8.88%
+9.09%
+5.34%
Most Trending
+12.90%
-18.60%
-8.88%
+9.09%
+5.34%
$PRIM Primoris Services hit a fresh 52-week high at $118.55, though hints at consolidation. With RSI at 79.25, the stock is in overbought territory. While fundamentals have been supportive, traders should watch for profit-taking near this level. Sustained momentum above $120 would confirm strength.
$ULTA Ulta Beauty also touched a 52-week high but sold off sharply. Volume surged well above average, suggesting strong selling pressure. RSI at 39.78 shows the stock may cool further before finding support. Holding above the 200-day ($418.91) is key for bulls.
$PRVA Privia Health crossed above its 200-day MA at $22.29, supported by an RSI of 69.36. The breakout above long-term resistance suggests improving momentum. Sustaining this level could pave the way for higher highs if volume follows through.
$ENVX Enovix slipped below its 200-day MA ($9.65), closing at $9.62 (-3.12%). RSI at 33.52 is nearing oversold, but the technical breach is a red flag. Bulls need to see a quick reclaim of $9.65 to avoid further downside pressure.
$HIMX Himax broke below its 200-day MA ($8.21), settling at $8.14. With RSI at 49.45 and trend bias down, momentum looks weak. Unless it reclaims $8.50 quickly, more downside is possible.
$CMI Cummins shows oversold signals with RSI at 65.85, hovering near key support levels. The sideways trend suggests consolidation before a possible bounce. Traders may watch for recovery toward the $410 zone.
$GRND Grindr is firmly oversold with RSI at 31.55. The stock trades below the 20-day MA ($17.18), but with selling pressure easing, a technical rebound could form. Aggressive traders may look for short-term recovery plays.
$HMY Harmony Gold bounced from oversold territory with RSI improving to 36.79. With strong volume (7.38M vs 3.89M avg), buyers are stepping in. A move above $15 would confirm reversal strength.
$TLX Telix Pharma is deeply oversold, reflected in sharp selling volume. With no major moving average supports near current price, patience is key. If RSI dips closer to 30, it could set up a contrarian bounce.
Yesterday at 01:22
Yesterday at 01:18
August 29, 2025 01:23 PM
August 29, 2025 01:07 PM
August 29, 2025 08:45 AM
August 29, 2025 07:17 AM
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Yesterday at 01:22
Yesterday at 01:18
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.